Key Market Indicator:
F&G: 23
25.437,00 NASDAQ · 47.724,00 DOW · 6.846,55 S&P · 4.219,18 Gold · 62,24 BRENT

One Community. One Spirit. N#1 Broker.
all asset classes · all possibilities

Switch View
Hedge the Peak | Protect your Profits
FR0005175080
Filter zurücksetzen
© Globe Newswire
26.11.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene announces the resume of trading of its shares on Euronext Paris as of the opening of the markets
Article
News Preview
Strasbourg, France, 27 November 2025, 00:15 a.m. CET – Transgene (Euronext Paris: TNG) had requested the suspension of trading of its shares (ISIN: FR0005175080) on Euronext Paris as from Wednesday, 26 November 2025, before market opening, pending the publication of the results of its capital increase....
Themefolio
Profiler
Peergroup
© Globe Newswire
26.11.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene Successfully Completes a Fundraising of c. €105 Million
Article
News Preview
This press release may not be distributed directly or indirectly in the United States, Canada, United Kingdom, Australia or Japan....
Themefolio
Profiler
Peergroup
© Globe Newswire
25.11.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Correction: Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris
Article
News Preview
Strasbourg, France, November 25, 2025, 7:45 p.m. CET – Transgene (Euronext Paris: TNG) has requested Euronext Paris to suspend trading of its shares (ISIN: FR0005175080) as of Wednesday, November 26, 2025, before the markets open, pending the publication of the results of its capital increase....
Themefolio
Profiler
Peergroup
Worth to know
20.10.2025
Short Selling Radar
USA, Europe, Asia
Track Short Selling Activities worldwide
More Info
Knowing what matters
Short sale statistics, hedge fund activities and much more user-friendly information
© Globe Newswire
25.11.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene Announces the Temporary Suspension of Trading of its Shares on Euronext Paris
Article
News Preview
Strasbourg, France, November 25, 2025, 7:45 p.m. CET – Transgene (Euronext Paris: TNG) has requested Euronext Paris to suspend trading of its shares (ISIN: FR0005175080) as of Wednesday, November 26, 2025, before the markets open, pending the publication of the results of its capital increase....
Themefolio
Profiler
Peergroup
Swarmalpha i/o · The Event Futures Prediction X
20.10.2025
© Globe Newswire
25.11.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Correction: Transgene launches a fundraising campaign for approximately 105 million euros
Article
News Preview
This press release may not be distributed directly or indirectly in the United States, the United Kingdom, Canada, Australia, or Japan. ...
Themefolio
Profiler
Peergroup
© Globe Newswire
25.11.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene launches a fundraising campaign for approximately 105 million euros
Article
News Preview
This press release may not be distributed directly or indirectly in the United States, the United Kingdom, Canada, Australia, or Japan....
Themefolio
Profiler
Peergroup
© Globe Newswire
06.11.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene to Showcase Potential of Proprietary VacDesignR® Computational Tool to Optimize Individualized Therapeutic Cancer Vaccines
Article
News Preview
Computational tool improves recombinant virus design efficiency and yield....
Themefolio
Profiler
Peergroup
© Globe Newswire
20.10.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene and BioInvent’s Armed Oncolytic Virus BT-001 Shows Positive Local, Abscopal, and Sustained Antitumoral Activity in Advanced Refractory Tumors
Article
News Preview
BT-001 in combination with pembrolizumab is well tolerated and shows sustained antitumoral activity in both injected and non-injected lesions...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.10.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene and BioInvent to Present Translational Data and Updated Clinical Results on Armed Oncolytic Virus BT-001, at ESMO 2025
Article
News Preview
Poster presentation on BT-001 in combination with pembrolizumab has shown tumor shrinkage in both injected and non-injected lesions...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.10.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene to Present New Immunological Data from Phase I Trial of Individualized Therapeutic Cancer Vaccine, TG4050, at SITC 2025
Article
News Preview
Strasbourg, France, October 3, 2025, 5:45 p.m.  CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, will present a poster highlighting in-depth analysis of the neoantigen-specific T cell response from the randomized Phase I trial of its individualized therapeuti...
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Availability of Transgene’s Half-Year Financial Report as of June 30, 2025
Article
News Preview
TRANSGENE (Paris: TNG) today announced that it has made available to the public and filed with the Autorité des marchés financiers its half-year financial report as of June 30, 2025....
Themefolio
Profiler
Peergroup
© Globe Newswire
16.09.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
2025 Half-year financial information
Article
News Preview
2025 Half-year financial information...
Themefolio
Profiler
Peergroup
Advertisment
20.10.2025
© Globe Newswire
16.09.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene’s Individualized Neoantigen Therapeutic Cancer Vaccine TG4050 Delivers Positive Randomized Phase I Data  Randomization to be Completed in Phase II Part in Q4 2025
Article
News Preview
2025 Half-Year Results and Business Update...
Themefolio
Profiler
Peergroup
© Globe Newswire
28.07.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene and BioInvent to Present Updated Data on Armed Oncolytic virus BT-001, at ESMO 2025
Article
News Preview
Poster presentation of updated data on BT-001 from the Phase I part of the ongoing Phase I/IIa study in solid tumors...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.07.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene Appoints Seasoned Industry Executive Emmanuelle Quilès to Board of Directors as Independent Director
Article
News Preview
Strasbourg, France, July 9, 2025, 5:45 p.m. CET — Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced the appointment of Emmanuelle Quilès as an independent Director to its Board of Directors. She succeeds Philippe Archinard, who is retiring from the B...
Themefolio
Profiler
Peergroup
© Globe Newswire
08.07.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2025
Article
News Preview
Strasbourg, July 8, 2025 – 06:00 pm CET...
Themefolio
Profiler
Peergroup
© Globe Newswire
19.06.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene Completes Initial Patient Screening in Phase II Part of TG4050 Trial in Operable Head and Neck Cancer
Article
News Preview
Phase I part showed 100% Disease-Free Survival (DFS) after a minimum of 2-year follow-up – providing clinical proof of principle for TG4050...
Themefolio
Profiler
Peergroup
© Globe Newswire
13.06.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene to Participate in Upcoming Meetings with Biotech Industry Leaders
Article
News Preview
Strasbourg (France), June 13, 2025, 8:30 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will meet institutional investors, scientists and leaders of the biotechnology ecosystem during the upcoming editions of:...
Themefolio
Profiler
Peergroup
© Globe Newswire
03.06.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene to Host Webcast on Positive TG4050 Head and Neck Cancer Data Presented at ASCO 2025
Article
News Preview
Strasbourg (France), June 3, 2025, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced it will host a live webcast to discuss the latest positive clinical data from its individualized neoantigen cancer vaccine, TG4050, presented at the...
Themefolio
Profiler
Peergroup
© Globe Newswire
01.06.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene and NEC Present Durable Disease-Free Survival and Sustained T Cell Responses at 24 Months with Individualized Cancer Vaccine TG4050
Article
News Preview
All patients in the treatment arm remain disease-free after a minimum of 2-year follow-up in the randomized Phase I trial in resected HPV-negative locally advanced head and neck cancer – Demonstrating clinical proof of principle for TG4050...
Themefolio
Profiler
Peergroup
© Globe Newswire
22.05.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene to Present 24-month Disease-Free Survival Data from All Patients in Phase I Part of Trial of Individualized Cancer Vaccine, TG4050, at ASCO 2025
Article
News Preview
24-month follow-up data from randomized Phase I part of the Phase I/II trial of TG4050 in resected locally advanced head and neck cancer selected for rapid oral presentationat ASCO on June 1st, 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.04.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene Provides Business and Financial Update for Q1 2025
Article
News Preview
TG4050: Updated randomized Phase I data to be presented in Rapid Oral Presentation at ASCO 2025...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.04.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Availability of Preparatory Documents for the Combined General Meeting of May 15, 2025
Article
News Preview
Strasbourg, France, April 24, 2025, 8:00 a.m. CET - Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies, announced that the documentation related to the Combined General Meeting (ordinary and extraordinary sessions) of Transgene’s shareholders is available....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.04.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Availability of Transgene’s 2024 Universal Registration Document (URD)
Article
News Preview
Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces that the French version of its 2024 Universal Registration Document was filed with the French Financial Markets Authority (Autorité des marchés financiers – AMF) on April 10, 2025, under number D.25-0243....
Themefolio
Profiler
Peergroup
© Globe Newswire
10.04.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Document d'Enregistrement Universel 2024
Article
News Preview
Document d'Enregistrement Universel 2024...
Themefolio
Profiler
Peergroup
© Globe Newswire
27.03.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene Achieves Key Milestones in 2024, Including Clinical Proof of Principle for Individualized Cancer Vaccine ̶ Strong Outlook for 2025
Article
News Preview
2024 Full-year results and business update...
Themefolio
Profiler
Peergroup
© Globe Newswire
21.01.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene to Participate in the Biomed Forum Investor Conference
Article
News Preview
Strasbourg (France), January 21, 2025, 5:45 PM CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, today announced that its management team will participate in the upcoming edition of the Biomed Forum, a conference for institutional investors. Organized by AllIn...
Themefolio
Profiler
Peergroup
© Globe Newswire
14.01.2025
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene Announces Financial Calendar for 2025
Article
News Preview
Strasbourg (France), January 14, 2025, 5:45 p.m. CET—Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, announces its financial reporting dates for 2025:...
Themefolio
Profiler
Peergroup
© Globe Newswire
07.10.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene to Present a Poster on Updated Data for TG4050 at SITC 2024
Article
News Preview
Transgene will present median 24-month follow up data from patients enrolled in the Phase I trial evaluating the individualized cancer vaccine TG4050 in the adjuvant treatment of head and neck cancer...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
2024 Half-Year Financial Report
Article
News Preview
2024 Half Year Financial Report...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene to Report Major Clinical Data before the end of 2024 – Confirmed Financial Visibility until Q4 2025
Article
News Preview
2024 Half-Year Results and Business Update...
Themefolio
Profiler
Peergroup
© Globe Newswire
24.09.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Availability of Transgene’s Half-Year Financial Report as of June 30, 2024
Article
News Preview
TRANSGENE (Paris: TNG) today announced that it has made available to the public and filed with the Autorité des marchés financiers its half-year financial report as of June 30, 2024....
Themefolio
Profiler
Peergroup
© Globe Newswire
14.09.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene and BioInvent’s Oncolytic Virus BT-001 Shows Promising Antitumor Activity in Ongoing Phase I/IIa Trial in Solid Tumors that Failed Previous Treatments
Article
News Preview
Preliminary data presented at ESMO 2024 demonstrate that BT-001 induces tumor regression in patients who failed previous anti-PD(L)-1 treatment...
Themefolio
Profiler
Peergroup
© Globe Newswire
09.09.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene and BioInvent to Present Promising Initial Phase I/IIa Data on Oncolytic Virus, BT-001, at ESMO 2024
Article
News Preview
BT-001 monotherapy showed stable disease and shrinkage of injected lesions in patients with advanced solid tumors....
Themefolio
Profiler
Peergroup
© Globe Newswire
27.08.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene — Preclinical Proof-of-Concept Data of Oncolytic Virus TG6050 published in JITC
Article
News Preview
These data, published in The Journal for ImmunoTherapy of Cancer (JITC), demonstrate that TG6050 induces tumor regression and profound remodeling of the tumor microenvironment...
Themefolio
Profiler
Peergroup
© Globe Newswire
31.07.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene annonce la mise à disposition d’un prospectus dans le cadre de la conversion en actions d’une partie de l’avance en compte-courant de TSGH
Article
News Preview
Ce communiqué ne peut être publié, transmis ou diffusé ou distribué, directement ou indirectement, aux États-Unis, au Canada, en Australie ou au Japon....
Themefolio
Profiler
Peergroup
© Globe Newswire
30.07.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene renforce son bilan par la conversion en actions d’une partie de l’avance en compte-courant de TSGH
Article
News Preview
Ce communiqué ne peut être publié, transmis ou diffusé ou distribué, directement ou indirectement, aux États-Unis, au Canada, en Australie ou au Japon....
Themefolio
Profiler
Peergroup
© Globe Newswire
22.07.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Transgene and BioInvent to Present Poster on Oncolytic Virus, BT-001, at ESMO 2024
Article
News Preview
Strasbourg, France, and Lund, Sweden, July 22, 2024, 8:00 a.m. CET – Transgene (Euronext Paris: TNG), a biotech company that designs and develops virus-based immunotherapies for the treatment of cancer, and BioInvent International AB (“BioInvent”) (Nasdaq Stockholm: BINV), a biotech company focused on the discovery and development of novel and firs...
Themefolio
Profiler
Peergroup
© Globe Newswire
10.07.2024
ISIN: FR0005175080
Transgene SA
TNG
LISTED
EURONEXT
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of June 30, 2024
Article
News Preview
Under the liquidity contract entrusted by Transgene to Natixis Oddo BHF SCA, as of June 30, 2024, the following resources were managed through the liquidity account:...
Themefolio
Profiler
Peergroup
Long/Short | Fractionals | Margin | Hedge · 4 powerful Trading App | MT4.MT5.ACTIVTRADER | TradingViewplus
Indices
DAX, DOW, S&P, FTSE...
Realtime Trading
With & without leverage
Currencies
EUR, USD, JPY, BRL, GBP ....
50 FX-Pairs
Top Conditions, Tied spreads, Mini/Micro
Commodities
Brent, WTI, Coffee, Wheat....
Long & Short
Crude oil, Agricultural & more
Metals
Gold, Silver, Palladium, Platinum
Hedging
Soft-,Heavy-, Precious Metals
Stocks & ETF
TSLA, NFLX, NVDA, MSFT, AAPL ....
Leveraged Equity Trading
USA, Europe, Asia
More information, click here

More sector specific news

Your Press Release is missing or you want share news over GICS11? Drop us a line.

Gamechanger in online marketing · Innovation as a service · Upgrade your own internet presence.

XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 Select Sector SPDRs
* * *
More Sector related Investment Ideas
XLB
XLE
XLU
XLY
XLF
XLP
XLV
XLK
XLC
XLI
XLRE
© 2025 WEBs Investments ETFs
About the newsfeed
#1
What types of information are provided on this portal - and what purpose does it serve?
The portal provides structured, stock market-relevant company information that is specifically assigned to a particular economic sector. The focus is on current announcements from official NewsWire sources, supplemented by company profiles, filter options by sector and sector-specific research aids. The aim is to offer an interested group of people a systematically structured research environment that improves their understanding of sector developments and corporate strategies.
#2
Why are companies categorized according to a certain system?
Financial markets consist of thousands of listed companies with very different business models. In order to create transparency and comparability, companies worldwide are assigned to standardized classifications. These classifications help investors to better analyze markets, identify sector-specific trends and make more targeted investment decisions.
#3
What classification standards exist for grouping companies?
There are various industry classifications that are used depending on the region or application. The best known include GICS (Global Industry Classification Standard), ICB (Industry Classification Benchmark), NAICS (North American Industry Classification System) and TRBC (Thomson Reuters Business Classification). Most institutional investors and ETFs worldwide use GICS or ICB as a benchmark.
#4
What classification standard is this financial information portal based on?
The portal uses the Global Industry Classification Standard (GICS), which was jointly developed by MSCI and S&P Dow Jones Indices. GICS is widely used in the institutional financial world and forms the basis for many global equity indices, ETFs and research systems.
#5
What exactly does GICS mean - and how is the system structured?
GICS stands for Global Industry Classification Standard. It is a hierarchical structure that divides listed companies worldwide into four levels: Sector, Industry Group, Industry Sector and Sub-Industry. In total, the system comprises 11 main sectors, over 60 industries and more than 150 sub-categories. It allows a consistent, internationally comparable analysis of economic activities.
#6
Why is GICS important in the financial world?
GICS offers a standardized language for investment decisions. It makes it possible to compare companies with similar business models - regardless of country, stock exchange or company size. Many investment funds, indices and research houses use GICS as a basis for portfolio construction, risk analysis or market screening. This means that it also makes sense for private investors to use this structure as a guide.
#7
Who decides which GICS sector a company is assigned to?
The allocation is made by the index providers MSCI and S&P Dow Jones on the basis of a company's main business segment. The decisive factor is the segment from which the company generates the majority of its sales or operating profit. Changes in the business model or strategic realignments can lead to a company being assigned to a different industry or even a different sector.
#8
What is meant by the GICS sector "Materials"?

The GICS "Materials" sector comprises companies that are active in the production, processing or refinement of raw materials. This includes industries such as chemicals, building materials, paper & forest products and the entire metallurgical and mining industry. The sector is highly cyclical and is particularly sensitive to economic fluctuations and changes in global demand.

#9
Which companies typically belong to the Materials sector?
Typical representatives are international groups from the areas of chemicals production (e.g. BASF), precious metal mining (e.g. Barrick Gold), building materials production (e.g. Heidelberg Materials) or industrial gases (e.g. Linde). The shares of these companies are often heavily dependent on commodity prices and play a central role in industrial value chains.
#10
Where does the company news on this page come from?
The news is based on verified and publicly available sources such as BusinessWire, GlobeNewswire, PR Newswire, EQS, Newsfile, ACCESSNewswire and other NewsWire services. These platforms are used by listed companies to publish mandatory ad hoc announcements, financial reports or strategic developments. All content is prepared in a structured manner and, if a corresponding categorization is possible, brought together in industry-specific clusters.
#11
How is the sector-specific mapping of messages carried out?
Categorization is based on structured metadata (e.g. ISIN, ticker, sector classification) and a combination of keyword analysis and GICS mapping. This ensures that all news is assigned to the correct sector and - if available - the correct sub-sector.
#12
Why is the materials sector particularly interesting for investors?
The Materials sector is closely linked to global industrial production and offers both cyclical growth opportunities and hedging opportunities against inflation and raw material shortages. In addition, many companies in this sector play a key role in future topics such as electromobility, the energy transition and sustainable building materials.
#13
What distinguishes this project from traditional financial information portals?
In contrast to generic portals, this project focuses exclusively and specifically on a particular sector. The advantage for interested investors: Sector-specific information, news, market movements and company profiles can be filtered and analyzed in a more targeted manner. This enables more in-depth research and greater relevance for thematic investment decisions.
#14
Are smaller companies also represented here or only large corporations?
The newsfeed takes into account both large caps and mid and small caps. As a clear mapping criterion is required in order to enable the most precise possible allocation to a cluster, the ISIN of the listed company is generally used for this purpose, provided that this can be made available or mapped via corresponding newsfeed parameters.
#15
How up-to-date are the displayed messages?
The content is updated regularly. The publication follows the publications of the information source, the NewsWire feeds of the underlying distributors. Incoming reports are automatically processed, classified and displayed on the page. Timestamps and source information ensure maximum transparency.
#16
Can I also filter the news by sub-sector?
Yes, this is a central feature of the site. Within a main sector, you can filter specifically for sub-sectors such as "Metals & Mining". For particularly popular industries or developments within a meta-sector, it is possible to deviate from standard clusters. Special categories with particular information value enable thematic analyses to be carried out even more precisely.
#17
Are there plans to process other metasectors in a similar way?
Yes, this financial information portal is part of an extensive project in which separate information portals are being created for all the main sectors. The aim is to provide investors with a systematic, sector-based research tool - regardless of index affiliation or provider perspective.
#18
Why do companies publish announcements via NewsWire services at all?
NewsWire services such as BusinessWire or PR Newswire fulfill a regulatory function: they enable companies to publish price-sensitive information publicly and without discrimination. In many countries, the use of such services is a prerequisite for fulfilling publication obligations under capital market law. They also enable companies to reach the media, analysts and investors in a targeted manner.
#19
Can private or inactive companies also appear in such notifications?
Generally not. The platform focuses exclusively on listed companies whose disclosures are based on regulatory requirements or corporate strategy measures. Although private or unlisted companies occasionally publish announcements, these are not systematically processed or classified here.
#20
What happens when a company changes its business model - does its sector classification also change?
Yes, as a rule - but not automatically. The responsible classification institutes (e.g. MSCI and S&P for GICS) regularly check the relevance and consistency of the classifications. If there is a significant change in a company's sales or profit profile, it may be reclassified to a different industry or even a different sector. This usually takes place after fixed review cycles or upon request.
#21
How is it ensured that a company is correctly categorized if it is active in several business areas?
The categorization is based on the dominant sales segment. If a company is active in several sectors but generates 70% of its turnover with chemical products, for example, it is assigned to the GICS sector "Materials" - even if it also has activities in the energy or transportation sector. In borderline cases, additional qualitative assessment criteria apply.
#22
Are there any legal risks in the further use of the displayed content?
The content comes from public sources, but is partially subject to copyright protection - particularly with regard to text structure and layout. The excerpts and links provided on this portal are made within the scope of permitted use (e.g. right to quote or editorial processing). However, commercial use by third parties is not permitted without the express permission of the original providers.
#23
Who can I contact if I have general questions or legal concerns?
A central contact point is available for general inquiries, information on company recordings, compliance issues or copyright-relevant aspects. In rare cases, for example in the case of erroneously published information or justified requests for deletion, a review and, if necessary, removal from the public feed can take place. Please only use the official contact option in the legal notice or at the bottom of the page.
#24
Is advertising or third-party content also displayed on the portal?
Yes, in defined areas the portal can display advertising content or product-specific information from third parties - for example on sector-related financial services, research offers or trading platforms. This content is clearly marked as advertising or partner information and is separate from the editorial or automatically processed company news.
#26
Can I give feedback on the platform or submit suggestions?
Absolutely - feedback is expressly welcome. The platform is an open information service that is continuously being developed. Comments on functionality, data quality, usability or thematic extensions help to optimize the service for the benefit of users. You can submit your suggestions informally via the contact page or special feedback forms.
#27
I am an information provider - can I cooperate with the portal?
Yes, the portal is open to content-related, technical or editorial cooperation, provided that this contributes to the quality, relevance or dissemination of the offering. If you offer content, interfaces or services that could be useful in the context of stock market-related information, we would be pleased to hear from you. The platform offers flexible integration options and a professional environment for quality-assured content.
#28
Can the platform technology also be used for other applications or partners?
Yes, the platform is based on a modular, scalable infrastructure that can be adapted to different information contexts and industry models. Technical components such as data aggregation, structuring logic, classification mechanisms and semantic filters can also be made available for external projects or individual applications on request. Please contact us for cooperation or license models.
#29
Can the underlying company data also be licensed or reused?
Structured access to selected master data of listed companies - such as GICS mapping, ISIN mapping, news feeds or metadata filters - is generally possible. The offer is aimed in particular at information service providers, research platforms or data-driven financial applications. Data can be provided via defined interfaces (e.g. API) or exportable formats, depending on the intended use and license framework.
#30
What forms of cooperation with external partners are conceivable?
Basically open. Possible forms of cooperation range from technical integrations and shared data models to content syndication or white label solutions. Partnerships with institutions that are looking for access to quality-assured data, dynamically structured news or sector-specific analyses - for example in the FinTech, media or research environment - are particularly interesting. We look forward to hearing from business development or product management departments.
#31
Why does this portal differ technically and conceptually from other information offerings?
Because no one from outside the industry is trying to understand the financial market here - but because the know-how comes from the heart of the financial world. The technical platform was developed by a team that combines in-depth market knowledge with innovative system design. The result: information architecture with real relevance, not shop window technology.
#32
What makes the technical solution particularly interesting for operators of their own financial portals?
In addition to high adaptability, the platform impresses with its modular structure and the consistent implementation of industry-specific logic - from GICS mapping to metadata filtering. For providers who operate their own information portals, sector-specific data structures, news feeds or visualizations can be quickly integrated on this basis - either as a white label, API module or embedded solution.
#33
Why can a collaboration go beyond traditional development services?
Because we don't just program, we think: The technological implementation is based on a deep understanding of market cycles, regulations, data formats and investor needs. Anyone who cooperates with this platform benefits from a sparring partner at eye level - both technically and professionally. This creates added value that goes far beyond pure IT expertise.
#34
Note on copyright and the processing of original content
The corporate news presented on this information portal is based on publicly accessible sources such as BusinessWire, GlobeNewswire, PR Newswire or comparable news services. The content is processed as part of an automated or editorially supported structuring process without changing, shortening or reinterpreting the content of the original information. This is so-called "as is" information, the form and content of which corresponds to the originally published announcement. The rights to the original texts remain unrestrictedly with the respective publishers or copyright holders. This portal merely assumes a structural categorization and allocation within the framework of a news-journalistic offer. Independent commercial reuse, systematic reproduction or other use of the content by third parties is only permitted within the framework of the statutory provisions or with the consent of the copyright holder.
About GICS Health
GICS Health is part of the GICS Eleven information portfolio, which focuses primarily on information from listed companies in the health sector. The sector classification serves as a guide to navigate quickly and conveniently through the latest industry-specific news. Individual peer group clusters complement the news offering.
About GICS Eleven

GICS Eleven (G11, GICS11) bundles topic-specific content and enables quick access to relevant information thanks to its gate function. The project is largely based on the Global Industry Classification Standard (GICS®), which was developed by MSCI and Standard & Poor's and enables a breakdown into sectors. GICS® consists of 11 sectors, 24 industry branches, 69 industries and 158 sub-industries.

GICS® is a registered trademark of MSCI Inc. and S&P Dow Jones Indices.

Member of 3R/RSQ Network
Digital Content
Network Alliance
Transparency - Reliability - Credibility
Information regarding Product Information
Monday, 01.12.2025, Calendar Week 49, 335th day of the year, 30 days remaining until EoY.